Camtek (CAMT) Competitors

Revvity (NYSE:RVTY) and Camtek (NASDAQ:CAMT) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, community ranking, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Is RVTY or CAMT more profitable?

Camtek has a net margin of 27.61% compared to Revvity's net margin of 9.81%. Camtek's return on equity of 24.99% beat Revvity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Revvity	9.81%	7.68%	4.62%
Camtek	27.61%	24.99%	14.81%

Is RVTY or CAMT a better dividend stock?

Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.2%. Camtek pays an annual dividend of $1.33 per share and has a dividend yield of 1.8%. Revvity pays out 12.7% of its earnings in the form of a dividend. Camtek pays out 55.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Does the MarketBeat Community favor RVTY or CAMT?

Camtek received 528 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 71.50% of users gave Camtek an outperform vote while only 61.70% of users gave Revvity an outperform vote.

Company	Underperform	Outperform
Revvity	Outperform Votes 29 61.70%	Underperform Votes 18 38.30%
Camtek	Outperform Votes 557 71.50%	Underperform Votes 222 28.50%

Which has more risk & volatility, RVTY or CAMT?

Revvity has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. Comparatively, Camtek has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500.

Do analysts recommend RVTY or CAMT?

Revvity currently has a consensus price target of $136.25, suggesting a potential upside of 20.31%. Camtek has a consensus price target of $114.11, suggesting a potential upside of 51.12%. Given Camtek's stronger consensus rating and higher probable upside, analysts plainly believe Camtek is more favorable than Revvity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revvity	0 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.77
Camtek	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has preferable earnings and valuation, RVTY or CAMT?

Revvity has higher revenue and earnings than Camtek. Camtek is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revvity	$2.76B	5.00	$270.39M	$2.21	51.24
Camtek	$429.23M	7.98	$118.51M	$2.42	31.20

Does the media favor RVTY or CAMT?

In the previous week, Camtek had 11 more articles in the media than Revvity. MarketBeat recorded 17 mentions for Camtek and 6 mentions for Revvity. Revvity's average media sentiment score of 1.27 beat Camtek's score of 0.57 indicating that Revvity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Revvity	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Camtek	6 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders believe in RVTY or CAMT?

86.7% of Revvity shares are owned by institutional investors. Comparatively, 41.9% of Camtek shares are owned by institutional investors. 0.6% of Revvity shares are owned by company insiders. Comparatively, 79.4% of Camtek shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Camtek beats Revvity on 13 of the 19 factors compared between the two stocks.